Achievements

Publication (English)

1. Kyuragi, S., Inamine, S., Ohgidani, M., Kato, T. A. Engineering of Human Blood-Induced Microglia-like Cells for Reverse-Translational Brain Research. J. Vis. Exp. (211), e66819, doi:10.3791/66819 (2024).
2. Masuda, R., Katsuki, R., Matsushima, T., Kyuragi, S., Nakao, T., & Kato, T. A. (2024). Does childhood maltreatment affect hikikomori via traits of modern-type depression?. Journal of affective disorders, 360, 50–54. doi: 10.1016/j.jad.2024.05.094.
3. Kyuragi, S., Matsushima, T., Matsuo, K., Nakao, T., & Kato, T. A. (2023). High-sensitivity C-reactive protein and bilirubin as possible biomarkers for hikikomori in depression: A case-control study. Psychiatry and clinical neurosciences, 77(8), 458–460. doi: 10.1111/pcn.13564.
4. Ohgidani, M., Kushima, I., Inamine, S., Kyuragi, S., Sagata, N., Nakao, T., Kanba, S., Ozaki, N., & Kato, T. A. (2023). A case of bipolar disorder with AIF1 (coding gene of Iba-1) deletion: A pilot in vitro analysis using blood-derived microglia-like cells. Psychiatry and clinical neurosciences, 77(2), 128–130. doi: 10.1111/pcn.13505.
5. Sato-Kasai, M., Kato, T. A., Ohgidani, M., Mizoguchi, Y., Sagata, N., Inamine, S., Horikawa, H., Hayakawa, K., Shimokawa, N., Kyuragi, S., Seki, Y., Monji, A., & Kanba, S. (2016). Aripiprazole inhibits polyI:C-induced microglial activation possibly via TRPM7. Schizophrenia research, 178(1-3), 35–43. doi: 10.1016/j.schres.2016.08.022.

Publication (Japanese)

1. 久良木 聡太,加藤 隆弘, “うつ病における炎症と免疫”, 炎症と免疫, 32(4):  294-297, 2024
2. 久良木 聡太、稲嶺 翔吾, 扇谷 昌宏, 加藤 隆弘,“ヒト血液単球由来ミクログリア様細胞を用いた橋渡しリバーストランスレーショナル研究”臨床精神医学, 53(4):435-442, 2024.

Presentations at International Academic Conferences

1. Kyuragi S, et al. “Antidepressant Prescription Trends in East Asian Country: An Overview of REAP-AD3 Survey.”, 2024 International Psychiatric Conference of Asia, Asia-Pacific, SAARC and Middle East Psychiatric Federations, Abu Dhabi, U.A.E., June 2, 2024. （Symposium）
2. Kyuragi S, et al. “Possible immunological pathophysiology in bipolar disorder: Reverse-translational research using induced microglia-like (iMG) cells.” 35th WORLD CONGRESS World Congress Collegium Internationale Neuro-Psychopharmacologicum,Tokyo, Japan, May 26, 2024. (Poster、Student Encouragement Award)
3. Kyuragi S, et al. “Possible immunological pathophysiology in bipolar disorder: Utility of induced microglia-like (iMG) cells for reverse-translational research.” SOCIETY OF BIOLOGICAL PSYCHIATRY 2024 Annual Meeting, Texas, U.S.A., May 11, 2024. (Poster)
4. Kyuragi S, et al. “Reverse-translational Research using cellular models.” 22nd Korea-Japan Young Psychiatrist’s Conference, Fukuoka, Japan, October 5, 2022. (口頭発表)

Presentations at Japanese Academic Conferences

1. 久良木聡太、他5名“双極性障害患者由来induced microglia-like cells (iMG細胞)を用いたRNA sequence解析” NEURO 2024、福岡、2024年7月26日　(口頭発表)
2. 久良木聡太、他5名“双極性障害患者由来induced microglia-like cells (iMG細胞)のRNA sequence解析” 第8回日本骨免疫学会ウインタースクール、長野、2024年1月31日　(ポスター)
3. 久良木聡太、他5名“双極性障害患者由来induced microglia-like cells (iMG細胞)のRNA sequence解析” 第45回日本生物学的精神医学会年会、東京、2023年11月6日　(ポスター)
4. 久良木聡太、他5名“SARS-Cov-2 スパイク蛋白に対するinduced microglia-like cells (iMG細胞)の反応性の解析”第66回日本神経化学会大会、兵庫、2023年7月7日　(ポスター)
5. 久良木聡太、他5名“SARS-Cov-2 スパイク蛋白に対するinduced microglia-like cells (iMG細胞)の反応性の解析” 第44回日本生物学的精神医学会年会、東京、2022年11月5日　(ポスター)

Books, etc.

1. Participation in the Japanese translation of “Diagnostic and statistical manual of mental disorders : DSM-5-TR. American Psychiatric Association, 2022.”
   Takahashi S, Ono H: DSM-5-TR 精神疾患の診断・統計マニュアル. IGAKU-SHOIN Ltd., 2023
2. Kato TA, Matsushima T, Matsuo K, Kyuragi S, Minohara T, Oishi M, Kayo M: 心のケアにたずさわる人が知っておきたい　精神系のくすり(Psychotropic drugs that mental health care providers should know about). MEDICUS SHUPPAN, Publishers Co., Ltd., 2022